The January issue of PME kicks off 2017 by analysing some of the seismic changes that are affect the industry over the next 12 months and beyond.
With barely a week to go until president-elect Trump’s inauguration, we have a stateside view of the Washington DC powershift and a look at the impact of his victory in last year’s US elections on the pharma, biotech and healthcare sectors.
On this side of the pond the UK’s decision to leave the EU looms just as large, and we consider what will be expected of the UK as the post-Brexit environment takes shape.
Change is also on the way for market access in Europe, with governments in Germany, France and the UK pursuing their own agendas for balancing access and affordability.
Proving it’s the theme of the month there is change too at Shire, whose UK and Ireland general manager Sebastian Stachowiak talks us through how his company has been transformed by its acquisition of Baxalta, where work is needed in NICE processes and what Brexit means for Shire.
Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.
PME is also available to download as an app for iPhone and iPad
